Down-Regulation of miR-96 by Bone Morphogenetic Protein Signaling is Critical for Vascular Smooth Muscle Cell Phenotype Modulation

被引:44
|
作者
Kim, Sunghwan [1 ]
Hata, Akiko [2 ]
Kang, Hara [3 ]
机构
[1] Catholic Univ Korea, Coll Med, Lab Dermatol Immunol, Seoul, South Korea
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA
[3] Incheon Natl Univ, Coll Life Sci & Bioengn, Div Life Sci, Inchon 406772, South Korea
基金
新加坡国家研究基金会;
关键词
BONE MORPHOGENETIC PROTEIN; VASCULAR SMOOTH MUSCLE CELLS; microRNA-96; TRIBBLES-LIKE PROTEIN 3; EXPRESSION; MICRORNAS; TRB3; DIFFERENTIATION; HYPERTENSION; PATHWAY; GENE;
D O I
10.1002/jcb.24730
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bone morphogenetic protein (BMP) signaling pathway is critical for the induction and maintenance of contractile phenotype in vascular smooth muscle cells (VSMCs). Inactivation of BMP signaling is common in abnormalities in vascular development and in vascular proliferative conditions, such as pulmonary artery hypertension. Herein, we identify microRNA-96 (miR-96) as a modulator of the VSMC phenotype in response to BMP4 signaling. We show that miR-96 is down-regulated by BMP4 treatment, which results in the derepression of a novel target, Tribbles-like protein 3 (Trb3). miR-96 targets a partially complementary sequence localized in the 3 UTR of Trb3. Trb3 is an essential positive regulator of the BMP signaling pathway and promotes contractile phenotype in VSMCs. In conclusion, our study demonstrates a novel mechanism of regulation of SMC-specific gene expression and induction of a VSMC contractile phenotype by the BMP4 signaling pathway via suppression of the miR-96-Trb3 axis. J. Cell. Biochem. 115: 889-895, 2014. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:889 / 895
页数:7
相关论文
共 50 条
  • [1] Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation
    Kim, Kwangho
    Lee, Seung Ho
    Kang, Hara
    FASEB JOURNAL, 2014, 28 (01):
  • [2] Down-regulation of Kruppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-β and Bone Morphogenetic Protein 4
    Davis-Dusenbery, Brandi N.
    Chan, Mun Chun
    Reno, Kelsey E.
    Weisman, Alexandra S.
    Layne, Matthew D.
    Lagna, Giorgio
    Hata, Akiko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (32) : 28097 - 28110
  • [3] Bone morphogenetic protein 2 induces an osteoblastic phenotype in vascular smooth muscle cells by activation of bone morphogenetic protein receptor 2 and smad signaling
    Johnson, Rebecca C.
    Loscalzo, Joseph
    Leopold, Jane A.
    CIRCULATION, 2006, 114 (18) : 179 - 180
  • [4] Expression and regulation of bone morphogenetic protein antagonists in vascular smooth muscle cells
    TT Maciel
    N Schor
    AH Campos
    Critical Care, 7 (Suppl 3):
  • [5] Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture
    Dorai, H
    Sampath, TK
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2001, 83A : S70 - S78
  • [6] The Bone Morphogenetic Protein Antagonist Gremlin Promotes Vascular Smooth Muscle Cell Apoptosis
    Maciel, Thiago Trovati
    Melo, Rosilene Santos
    Campos, Alexandre Holthausen
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 (04) : 325 - 332
  • [7] Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype
    Mabie, PC
    Mehler, MF
    Kessler, JA
    JOURNAL OF NEUROSCIENCE, 1999, 19 (16): : 7077 - 7088
  • [8] Transcriptional regulation of vascular smooth muscle cell phenotype
    K. Walsh
    A. Takahashi
    Zeitschrift für Kardiologie, 2001, 90 (Suppl 3): : 12 - 16
  • [9] Adiponectin and the Regulation of Vascular Smooth Muscle Cell Phenotype
    Cullen, Abigail
    Ismaeel, Ahmed
    Koutakis, Panagiotis
    Salazar, Gloria
    CIRCULATION, 2019, 140
  • [10] siRNA mediated down-regulation of proteins in intact vascular smooth muscle
    Smolock, Elaine M.
    Wang, Tanchun
    Nolt, Jocelyn K.
    Moreland, Robert S.
    CLINICAL SCIENCE, 2007, 113 (7-8) : 6P - 7P